Akoustis Technologies Inc reports results for the quarter ended in June - Earnings Summary

Aktis Oncology

30/08/2021 12:52

* Akoustis Technologies Inc  AKTS.OQ  reported a quarterly
adjusted loss of 23 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 19 cents per share.
* Revenue rose 489.3% to $2.16 million from a year ago; 
analysts expected $2.50 million. 
* Akoustis Technologies Inc's reported EPS for the quarter was a
loss of 20 cents​.
* The mean earnings estimate of analysts was unchanged in the
last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Akoustis Technologies Inc shares had fallen by 6.7% this
quarter and lost 18.3% so far this year.
* The company reported a quarterly loss of $10.12 million.
* Wall Street's median 12-month price target for Akoustis
Technologies Inc is $16.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 30 at 11:52 a.m.  ​All
figures in US dollars unless otherwise stated